<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- Coronavirus: Delta is now also dominating in Germany – new measures? Jul 8, 2021
- Regulation for incoming and return travelers: Baden-Württemberg.de Apr 18, 2021
- Coronavirus, Cuba beats Italy one to zero on the vaccine Jul 11, 2021
- Military exercise of unprecedented scale in France in 2023 Nov 17, 2022
- The debate over the origin of covid-19 is rekindled by a new US report. May 28, 2021
- The doctors explained why you should eat avocado every day May 23, 2020
- Can a Child Suffer Medical Negligence? Aug 10, 2021
